Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://edgaraztmq.liberty-blog.com/31600731/semaglutide-a-breakthrough-in-managing-diabetes-weight-loss-and-cardiovascular-health